- Home
- AS vs TECH Comparison
AS vs TECH Comparison
Compare AS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AS
- TECH
- Stock Information
- Founded
- AS 1950
- TECH 1976
- Country
- AS Finland
- TECH United States
- Employees
- AS N/A
- TECH N/A
- Industry
- AS
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AS
- TECH Health Care
- Exchange
- AS NYSE
- TECH Nasdaq
- Market Cap
- AS 13.3B
- TECH 12.0B
- IPO Year
- AS 2024
- TECH 1989
- Fundamental
- Price
- AS $28.59
- TECH $64.92
- Analyst Decision
- AS Buy
- TECH Buy
- Analyst Count
- AS 14
- TECH 7
- Target Price
- AS $26.07
- TECH $84.29
- AVG Volume (30 Days)
- AS 2.8M
- TECH 1.6M
- Earning Date
- AS 02-25-2025
- TECH 02-05-2025
- Dividend Yield
- AS N/A
- TECH 0.49%
- EPS Growth
- AS N/A
- TECH N/A
- EPS
- AS N/A
- TECH 0.98
- Revenue
- AS $4,843,300,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- AS $21.01
- TECH $7.50
- Revenue Next Year
- AS $14.98
- TECH $9.15
- P/E Ratio
- AS N/A
- TECH $66.26
- Revenue Growth
- AS 13.38
- TECH 4.46
- 52 Week Low
- AS $10.11
- TECH $61.16
- 52 Week High
- AS $34.00
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- AS 40.74
- TECH 29.97
- Support Level
- AS $30.30
- TECH $63.51
- Resistance Level
- AS $31.50
- TECH $67.19
- Average True Range (ATR)
- AS 1.28
- TECH 2.76
- MACD
- AS -0.40
- TECH -0.71
- Stochastic Oscillator
- AS 8.88
- TECH 8.94
About AS AMER SPORTS INC
Amer Sports manages a diverse portfolio of 10 outdoor and action sports brands that collectively generated revenue of $4.4 billion in 2023. Although primarily owned by the Chinese conglomerate Anta Sports, Amer operates with a degree of autonomy. In its rapidly expanding China business, the company is subject to closer oversight, but it manages its operations outside of China with relative independence. In 2023, the firm generates 40% of its revenue from the Americas, 33% from Europe, the Middle East, and Africa, 19% from China, and 7% from Asia-Pacific, excluding China.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.